Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Comparing oxazaphosphorines for treating Ewing sarcoma: is the answer important two decades later?

Comparing oxazaphosphorines for treating Ewing sarcoma: is the answer important two decades later? J Clin Oncol. 2014 Aug 10; 32(23):2401-2.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.